Back to search

Article

Multi‑omics factor analysis reveals a RAS mutant-like metabolically distinct AML subgroup resistant to venetoclax

2026-06-16

Abstract excerpt

<title>Abstract</title> <p> Acute myeloid leukemia (AML) exhibits extensive clonal and functional heterogeneity, limiting the ability of current genotype-based classifications to predict treatment response. We applied multi-omics factor analysis (MOFA) in a cohort of AML cases, integrating mutational status, proteomics, metabolomics, and two <italic>ex vivo</italic> drug screens comprising 115 agents targeting...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3b8d3f5c-4185-59da-8f3a-43cc5e377ba8
DOI
10.21203/rs.3.rs-9859908/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Multi‑omics factor analysis reveals a RAS mutant-like metabolically distinct AML subgroup resistant to venetoclaxDOI 10.21203/rs.3.rs-9859908/v1
Select a neighboring publication to make it the new centre.